.png){kind=icon}
返回
mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age
.png){kind=icon}
OA
AI
DOI：10.3390/diagnostics14010038.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Background: Vascular anomalies often result in aesthetic flaws, pain, and impair the quality of life. They require challenging treatments that frequently do not provide the desired results. The mammalian target of rapamycin (mTOR) is directly involved in the development of these malformations. However, the exact mechanism behind mTOR dysregulation has not been unambiguously defined. The purpose of this study is to investigate the activation of selected substrates of mTOR to partially assess its involvement in the disease process. Methods: We analyzed tissue samples collected from patients with vascular anomalies treated in our department. We included patients with histopathological diagnoses of lymphatic, venous, capillary malformations, mixed lesions, and a control group of healthy skin samples. We stained the samples using H and E and immunohistochemistry. We used primary antibodies against p70 S6 Kinase, 4EBP1, and p-4EBP1. We graded their color reactions. The statistical analyses were performed using the FactoMineR and factoextra R v.4.1 packages. p-values < 0.05 were considered statistically significant. Results: The analysis of 82 patients showed that healthy tissue vessels expressed lower levels of tested mTOR pathway substrates compared to high activation in vascular malformations. Elevated substrate expression in a comparison between sexes revealed higher P-4EBP1 expression in the female malformation group. We observed a decrease in mTOR substrate expression with age. Conclusion: The higher expression of mTOR substrates in vascular malformations compared to healthy tissue confirms their involvement in abnormal vascular development. Age-related changes in mTOR substrate expression highlight the need for timely intervention. Our study contributes to the understanding of the mTOR signaling pathway in vascular malformations and highlights its potential as a therapeutic target, contributing to personalized medicine.
Keyword:
sirolimus
rapamycin
vascular anomalies
lymphatic malformation
venus malformation
mTOR
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.3
论文数:
2.0W
被引数:
4.6W
机构
引用论文
Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform HemangioendotheliomaKaposi型血管内皮瘤中mTOR通路相关蛋白的免疫组织化学分析.png)
DERMATOLOGY
DERMATOLOGYIF2.7
PREAI
分享收藏Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA)REGENERATIVE THERAPYOAAI
REGENERATIVE THERAPYIF3.5
OAAI分享收藏Electrocardiographic Findings of Heart Rate and Conduction Times in Athletic Students and Sedentary Control Subjects运动学生与久坐对照组的心率及传导时间的心电图表现Cardiology
CardiologyIF0
PREAI
分享收藏Residual Thermal Stresses Simulation of Television Panel in the Forming Process. Part 2: Simulations and Validation电视面板成形过程中的残余热应力模拟。第二部分：模拟与验证
PREAI
分享收藏
查看更多内容